Parkinsonism in FMR1 premutation carriers may be indistinguishable from Parkinson disease.

No abstract is available for this paper.

• Publication year

  2009

• Venue

  Parkinsonism & Related Disorders

• Publication date

  2009-02-01

• Fields of study

  Medicine

• Identifiers
  DOI 10.1016/j.parkreldis.2008.04.037PMID 18565783PMCID PMC2685192
• External record

  Open on Semantic Scholar

• Source metadata

  Semantic Scholar, PubMed

• No claims are published for this paper.

• No concepts are published for this paper.

• FMR1 CGG repeat length predicts motor dysfunction in premutation carriers

  2008cited by this paper
• Screen for excess FMR1 premutation alleles among males with parkinsonism.

  2007cited by this paper
• CGG repeat length correlates with age of onset of motor signs of the fragile X‐associated tremor/ataxia syndrome (FXTAS)

  2007cited by this paper
• Prevalence of FMR1 Repeat Expansions in Movement Disorders

  2006cited by this paper
• Parkinsonism, dysautonomia, and intranuclear inclusions in a fragile X carrier: A clinical–pathological study

  2006cited by this paper
• Parkinsonism, FXTAS, and FMR1 premutations

  2005cited by this paper
• Evidence for, and a spectrum of, neurological involvement in carriers of the fragile X pre‐mutation: FXTAS and beyond

  2005cited by this paper
• Premutations in the FMR1 gene as a modifying factor in Parkin‐associated Parkinson's disease?

  2005cited by this paper
• Penetrance of the fragile X-associated tremor/ataxia syndrome in a premutation carrier population.

  2004cited by this paper
• Premutation alleles associated with Parkinson disease and essential tremor.

  2004cited by this paper
• Diagnostic criteria for Parkinson's disease

  2003cited by this paper
• Neuronal intranuclear inclusions in a new cerebellar tremor/ataxia syndrome among fragile X carriers.

  2002cited by this paper
• Diagnostic criteria for Parkinson disease.

  1999cited by this paper
• Unified Parkinson's Disease Rating Scale

  1987cited by this paper
• Members of the UPDRS Development Committee. Unified Parkinson's Disease Rating Scale

  1987cited by this paper

• Age-dependent impairment of dopamine D1 receptor signalling in mouse striatum by FMR1 variant P626L

  2025cites this paper
• Mitochondrial dysfunction in Fragile X syndrome and Fragile X-associated tremor/ataxia syndrome: prospect use of antioxidants and mitochondrial nutrients

  2024cites this paper
• Parkinson's Disease Polygenic Risk Score and Neurological Involvement in Carriers of the FMR1 Premutation Allele: A Case for Genetic Modifier

  2024cites this paper
• Parkinsonism in complex neurogenetic disorders: lessons from hereditary dementias, adult-onset ataxias and spastic paraplegias

  2023cites this paper
• FMR1 Carriers Report Executive Function Changes Prior to Fragile X‐Associated Tremor/Ataxia Syndrome: A Longitudinal Study

  2023cites this paper
• A Longitudinal Study of Executive Function in Daily Life in Male Fragile X Premutation Carriers and Association with FXTAS Conversion

  2023cites this paper
• Screening for the FMR1 premutation in Greek patients with late-onset movement disorders.

  2022cites this paper
• Parkinsonism and tremor syndromes.

  2021cites this paper
• X‐Linked Parkinsonism: Phenotypic and Genetic Heterogeneity

  2021cites this paper
• Optimal time lags from causal prediction model help stratify and forecast nervous system pathology

  2021cites this paper
• Dopaminergic Dysregulation in Syndromic Autism Spectrum Disorders: Insights From Genetic Mouse Models

  2021cites this paper
• The Role of Alpha-Synuclein and Other Parkinson’s Genes in Neurodevelopmental and Neurodegenerative Disorders

  2020cites this paper
• A Chinese case of fragile X-associated tremor/ataxia syndrome (FXTAS) with orthostatic tremor:case report and literature review on tremor in FXTAS

  2020cites this paper
• Aging with Autism Departs Greatly from Typical Aging

  2020cites this paper
• Tremorography in fragile X-associated tremor/ataxia syndrome, Parkinson's disease and essential tremor

  2020cites this paper
• Prodromal Markers of Upper Limb Deficits in FMR1 Premutation Carriers and Quantitative Outcome Measures for Future Clinical Trials in Fragile X‐associated Tremor/Ataxia Syndrome

  2020cites this paper
• Parkinsonism Versus Concomitant Parkinson's Disease in Fragile X–Associated Tremor/Ataxia Syndrome

  2020cites this paper
• [Fragile X associated tremor/ataxia syndrome: its clinical presentation, pathology, and treatment].

  2019cites this paper
• The spectrum of tremor among carriers of the FMR1 premutation with or without the fragile X-associated tremor/ataxia syndrome (FXTAS).

  2019cites this paper
• Fragile X-associated tremor/ataxia syndrome

  2019cites this paper
• Cerebellar syndrome and cognitive dysfunction with characteristic MRI findings in fragile X-associated tremor ataxia syndrome: A Case Report

  2019cites this paper
• Loss of fragile X mental retardation protein precedes Lewy pathology in Parkinson’s disease

  2019cites this paper
• Striatal dopaminergic dysregulation and dystonia-like movements induced by sensorimotor stress in a pharmacological mouse model of rapid-onset dystonia-parkinsonism.

  2019cites this paper
• Frequency of SCA8, SCA10, SCA12, SCA36, FXTAS and C9orf72 repeat expansions in SCA patients negative for the most common SCA subtypes

  2018cites this paper
• PET Molecular Imaging in Familial Parkinson's Disease.

  2018cites this paper
• More than meets the eye : an unusual Parkinson ’ s disease mimic CASE REPORT

  2018cites this paper
• Clinical implication of FMR1 intermediate alleles in a Spanish population

  2018cites this paper
• Cognitive Deficits and Associated ERP N400 Abnormalities in FXTAS With Parkinsonism

  2018cites this paper
• Fragile X syndrome and fragile X-associated tremor ataxia syndrome.

  2018cites this paper
• An updated review of Parkinson's disease genetics and clinicopathological correlations

  2017cites this paper
• Parkinsonism and Related Disorders

  2016cites this paper
• Clinical Phenotype of Adult Fragile X Gray Zone Allele Carriers: a Case Series

  2016cites this paper
• Fragile X-Associated Tremor/Ataxia Syndrome (FXTAS) Motor Dysfunction Modeled in Mice

  2016cites this paper
• An Association of Fragile X Associated Tremor/Ataxia Syndrome (FXTAS) with Three Common Neurological Problems: A Review

  2016cites this paper
• Fragile X-associated tremor/ataxia syndrome: phenotypic comparisons with other movement disorders

  2016cites this paper
• Endolysosomal Dysfunction in Parkinson Disease: The Role of Disease Mutations in ATP13A2 and LRRK2.

  2016cites this paper
• Non-Parkinsonian Movement Disorders

  2015cites this paper
• Fragile X–associated tremor/ataxia syndrome

  2015cites this paper
• High rates of parkinsonism in adults with autism

  2015cites this paper
• Mouse Models of the Fragile X Tremor/Ataxia Syndrome (FXTAS) and the Fragile X Premutation

  2015cites this paper
• Peripheral neuropathy and parkinsonism: a large clinical and pathogenic spectrum

  2014cites this paper
• In the Gray Zone in the Fragile X Gene: What are the Key Unanswered Clinical and Biological Questions?

  2014cites this paper
• Parkinsonism in fragile X-associated tremor/ataxia syndrome (FXTAS): revisited.

  2014cites this paper
• Molecular Advances Leading to Treatment Implications for Fragile X Premutation Carriers

  2014cites this paper
• Advances in clinical and molecular understanding of the FMR1 premutation and fragile X-associated tremor/ataxia syndrome.

  2013cites this paper
• Current Gaps in Understanding the Molecular Basis of FXTAS

  2012cites this paper
• The fragile X-associated tremor ataxia syndrome.

  2012cites this paper
• FXTAS

  2012cites this paper
• Vasoactive Intestinal Peptide Enhances Striatal Plasticity and Prevents Dopaminergic Cell Loss in Parkinsonian Rats

  2012cites this paper
• Fragile X-associated tremor/ataxia syndrome.

  2012cites this paper
• Fragile X-Associated Tremor Ataxia Syndrome: The Expanding Clinical Picture, Pathophysiology, Epidemiology, and Update on Treatment

  2012cites this paper
• Neurodegeneration the RNA way.

  2012cites this paper
• White matter changes in basis pontis in small expansion FMR1 allele carriers with parkinsonism

  2011cites this paper
• Rodzinne występowanie zespołu FXTAS powodowanego premutacją w genie FMR1

  2011cites this paper
• [Familial occurrence of FXTAS caused by premutation in the FMR1 gene].

  2011cites this paper
• FMR1 gray‐zone alleles: Association with Parkinson's disease in women?

  2011cites this paper
• Clinical Neurological Phenotype of FXTAS

  2010cites this paper
• FMR1 gene expansion and scans without evidence of dopaminergic deficits in parkinsonism patients.

  2010cites this paper
• Multiple system atrophy and colon inertia

  2010cites this paper
• [Neurological signs in the adult with fragile-X premutation].

  2010cites this paper
• Atypical parkinsonism with apraxia and supranuclear gaze abnormalities in type 1 Gaucher disease. Expanding the spectrum: Case report and literature review

  2010cites this paper
• Olfactory dysfunction in Japanese patients with idiopathic REM sleep behavior disorder: Comparison of data using the university of Pennsylvania smell identification test and odor stick identification test for Japanese

  2010cites this paper
• Multiple‐system atrophy presenting with low rectal compliance and bowel pain

  2010cites this paper
• Related to the New Topics Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson ’ s Disease

  2010cites this paper
• Primary progressive freezing gait in a patient with CO‐induced parkinsonism

  2010cites this paper
• Manifestaciones neurológicas en el adulto con premutación X frágil

  2010cites this paper
• Parkinsonism and cognitive decline in a fragile X mosaic male

  2010cites this paper
• The fragile x-associated tremor and ataxia syndrome (FXTAS).

  2010cites this paper
• Congenital mirror movements in Parkinson's disease: Clinical and neurophysiological observations

  2010cites this paper
• Related to the New Topics Transient Amantadine-Induced Musical Hallucinations in a Patient with Parkinson ’ s Disease

  2010cites this paper
• The Epidemiology of FXTAS

  2010cites this paper
• Rare and serious cardiac side effects during ropinirole titration

  2010cites this paper
• Valproate‐induced reversible hemichorea

  2010cites this paper
• Transient amantadine‐induced musical hallucinations in a patient with Parkinson's disease

  2010cites this paper
• Small CGG repeat expansion alleles of FMR1 gene are associated with parkinsonism

  2009cites this paper
• Expansion of an FMR1 grey-zone allele to a full mutation in two generations.

  2009cites this paper